Recombinant CTLA-4 (Ipilimumab Biosimilar) 抗体
This anti-CTLA-4 (Ipilimumab Biosimilar) antibody is a Human 单克隆 antibody detecting CTLA-4 (Ipilimumab Biosimilar) in FACS, ELISA, BLI, Func 和 SPR. Suitable for 人.
Quick Overview for Recombinant CTLA-4 (Ipilimumab Biosimilar) 抗体 (ABIN7581353)
抗原
CTLA-4 (Ipilimumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
标记
This CTLA-4 (Ipilimumab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
原理
- Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab)
-
产品特性
- Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.2 kDa.
-
纯度
- >95 %
-
亚型
- IgG1
-
-
anti-CTLA-4 (Ipilimumab Biosimilar) antibody
Research Grade 适用: 人 FACS, ELISA 宿主: Human Monoclonal unconjugated Recombinant Antibody
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- 1 mg/mL
-
缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
储存条件
- 4 °C,-80 °C
-
储存方法
- +4°C,-80°C
-
-
- CTLA-4 (Ipilimumab Biosimilar)
-
物质类
- Biosimilar
-
分子量
- 145.2 kDa
-
UniProt
- P16410
抗原
-
You are here:
